Akira Nishio

8PUBLICATIONS
26CO-AUTHORS
AutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 21, 2026
Autoimmune hepatitis with negative antinuclear antibody and normal early-phase IgG: diagnosis supported by histology, IgG dynamics, and steroid responsiveness.

|Apr 09, 2026
Carbonic anhydrase 9 as a circulating biomarker and therapeutic target in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab.

Yu Sato, Takahiro Kodama, Kazuki Maesaka

|Mar 30, 2026
Systemic immune profiling uncovers divergent mechanisms and predictive biomarkers of response to combination immunotherapies in hepatocellular carcinoma.

Akira Nishio, Takahiro Kodama, Kazuma Daiku

|Sep 18, 2024
High serum growth differentiation factor 15 is a risk factor for the occurrence of hepatocellular carcinoma in chronic hepatitis B patients treated with nucleos(t)ide analogs.

Emi Sometani, Hayato Hikita, Kazuhiro Murai

|Jan 21, 2023
Thrombospondin-2 as a Predictive Biomarker for Hepatocellular Carcinoma after Hepatitis C Virus Elimination by Direct-Acting Antiviral.

Takayuki Matsumae, Takahiro Kodama, Yuki Tahata

|Sep 16, 2022
Serum neutralization activity declines but memory B cells persist after cure of chronic hepatitis C.

Akira Nishio, Sharika Hasan, Heiyoung Park

Pageof 2

Frequent Collaborators

4 joint publications

Takahiro Kodama

2 joint publications

Barbara Rehermann

2 joint publications

Seiichi Tawara

2 joint publications

Kazuhiro Murai